Genetic variation in apolipoprotein H (β2-glycoprotein I) affects the occurrence of antiphospholipid antibodies and apolipoprotein H concentrations in systemic lupus erythematosus

Lupus

Volumn 8, Issue 9, 1999, Pages 742-750

  Kamboh, M Ilyas ^a,b   Manzi, Susan ^b,c   Mehdi, Haider ^a   Fitzgerald, Shirley ^c   Sanghera, Dharambir K ^a   Kuller, Lewis H ^b   Atson, Christopher E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid antibodies; Apolipoprotein H; Genetics; SLE; 2 glycoprotein I

Indexed keywords

BETA2 GLYCOPROTEIN 1; PHOSPHOLIPID ANTIBODY;

ADULT; ALLELE; ARTICLE; CODON; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE DOSAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MUTATION RATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0344577976     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678840909     Document Type: Article

References (34)

1. Kotzin BL. Systemic lupus erythematosus. Cell 1996; 85: 303-306.
2. Hahn BH. An overview of the pathogenis of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds). Duboiś Lupus Erythematosus 5th edn. Williams and Wilkins: Baltimore, 1997; pp 69-75.
3. Vyse TJ, Kotzin BL. Genetic basis of systemic lupus erythematosus. Curr Opin Immunol 1996; 8: 843-851.
4. Arnett FC. The genetics of human lupus. In Wallace DJ, Hahn BH (eds). Duboiś Lupus Erythematosus 5th edn. Williams and Wilkins: Baltimore, 1997; pp 77-117.
5. Gharavi AE, Wilson WA. Antiphospholipid antibodies. In Wallace DJ, Hahn BH (eds). Duboiś Lupus Erythematosus 5th edn. Williams and Wilkins: Baltimore, 1997; pp 471-491.
6. Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus 1998; 7 (Suppl 2): S132-S134.
7. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: β2-glycoprotein 1 (apolipoprotein H). Proc Ntl Acad Sci USA 1990; 87: 4120-4124.
8. Galli M, Comfurius P, Maassen C et al. Anticrdiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-1547.
9. Jones JV, James H, Tan MH, Mansor M. Antiphospholipid antibodies require β2-glycoprotein I (apolipoprotein H) as cofactor. J Rheumatol 1992; 19: 1397-1402.
10. Arvieux J, Roussel B, Ponard D, Colomb MG. IgG2 subclass restriction of anti-β2 glycoprotein I antibodies in autoimmune patients. Clin Exp Immunol 1994; 95: 310-315.
11. Cabiedes J, Cabral AR, Alarcón-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995; 22: 1899-1906.
12. Cabral AR, Cabiedes J, Alarcón-Segovia D. Antibodies to phospholipid-free β2-glycoprotein-I in patients with primary antiphospholipid syndrome. J Rheumatol 1995; 22: 1894-1898.
13. Lozier J, Takahashi N, Putnam FW. Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci USA 1984; 81: 3640-3644.
14. Steinkasserer A, Estaller C, Weiss E, Sim RB. Complete nucleotide and deduced amino acid sequence of human β2-glycoprotein I. Biochem J 1991; 277: 387-391.
15. Mehdi H, Nunn M, Steel DM et al. Nucleotide sequence and expression of the human gene encoding apolipoprotein H. Gene 1991; 108: 293-298.
16. Cleve H. Genetic studies on the deficiency of β2-glycoprotein I of human serum. Hum Genet 1968; 5: 294-304.
17. Koppe AI, Walter H, Chopra VP, Bajatzadeh M. Investigation on the genetics and population genetics of the β2-glycoprotein I polymorphism. Hum Genet 1970; 9: 164-171.
18. Propert DN. The relationship of sex, smoking status, birth rank and parental age to β2-glycoprotein I levels and phenotypes in a sample of Australian Caucasian adults. Hum Genet 1978; 43: 281-288.
19. Walter H, Hilling M, Brachtel R, Hitzeroth HW. On the population genetics of β2-glycoprotein I. Hum Hered 1979; 29: 236-241.
20. Kamboh MI, Ferrell RE, Sepehrnia B. Genetic studies of human apolipoproteins. IV. Structural heterogeneity of apolipoprotein H (β2-glycoprotein I). Am J Hum Genet 1988; 42: 452-457.
21. Kamboh MI, Wagenknecht DR, McIntyre J, Heterogeneity of the apolipoprotein H*3 allele and its role in affecting the binding of apolipoprotein H (β2-glycoprotein I) to anionic phospholipid. Hum Genet 1995; 95: 385-388.
22. Sanghera DK, Kristensen T, Hamman RF, Kamboh MI. Molecular basis of the apolipoprotein H (β2-glycoprotein I) protein polymorphism. Hum Genet 1997; 100: 57-62.
23. Sanghera DK, Wagenknecht DR, McIntyre JA, Kamboh MI. Identification of structural mutations in the fifth domain of apolipoprotein H (β2-glycoprotein I) which affect phospholipid binding. Hum Mol Genet 1997; 6: 311-316.
24. Steinkasserer A, Dorner C, Wurzner R, Sim RB. Human β2-glycoprotein I: molecular analysis of DNA and amino acid polymorphism. Hum Genet 1993; 91: 401-402.
25. Eichner JE, Kuller LH, Kamboh MI, Ferrell RE. Phenotypic effects of apolipoprotein structure variation on lipid profiles. I. APOH and quantitative lipid measures in the Healthy Women Study. Genet Epidemiol 1989; 6: 311-318.
26. Mehdi H, Kaplan MJ, Anlar FY et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 1994; 68: 2415-2424.
27. McNally T, Mackie IJ, Isenberg DA, Machin SJ. Immunoelectrophoresis and ELISA techniques for assay of plasma β2 glycoprotein-I and the influence of plasma lipids. Thromb Res 1993; 72: 275-286.
28. Mehdi H, Aston CE, Sanghera DK et al. Genetic variation in the apolipoprotein H (β2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet 1999; in press (online publication No. D01 10.1007/s004399800089).
29. Galli M, Cortelazzo, Daldossi M, Barbui T. Increased levels of β2-glycoprotein I (aca-cofactor) in patients with lupus anticoagulant. Thromb Haemost 1992; 67: 386.
30. Oosting J, Derksen R, Entjes H et al. Lupus anticoagulant activity is frequently dependent on the presence of β2-glycoprotein I. Thromb Haemost 1992; 67; 499-502.
31. Kamboh MI, Mehdi H. Genetics of apolipoprotein H (β2-glycoprotein I) and anionic phospholipid binding. Lupus 1998; 7(Suppl 2): S10-S13.
32. Koike T, Ichikawa K, Atsumi T et al. Epitopeson β2-GPI recognized by anticardiolipin antibodies. Lupus 1998; 7(Suppl 2): S14-S17.
33. Marquis D, Victoria E, Iverson GM. β2GPI-dependent anticardiolipin autoantibodies recognize an epitope on the first domain of βGPI. Lupus 1998; 7(Suppl 7): S176 (abstract).
34. Horbach DA, van Oort E, Tempelman MJ et al. The prevalence of a non-phospholipid-binding form of β2-glycoprotein I in human plasma. Consequences for the development of anti-β2-glycoprotein I antibodies. Thromb Haemost 1998; 80: 791-797.